US Codex
U.S.C.
Notes

§10705. Definitions — Inbound Citations

34 U.S.C. § 10705

Cited by 35 provisions in release 119-102.

Citations to 34 U.S.C. § 10705 as a whole

  • 34 U.S.C. § 10653(a)
    Go to provision →
    (a) Not later than one year after August 16, 2022, the Attorney General, acting through the Director of the Bureau of Justice Assistance, in consultation with the Director of the Centers for Disease Control and Prevention and the Assistant Secretary for Mental Health and Substance Use, shall solicit best practices regarding techniques to interact with persons who have a traumatic brain injury, an acquired brain injury, or post-traumatic stress disorder from first responder, brain injury, veteran, and mental health organizations, health care and mental health providers, hospital emergency departments, and other relevant stakeholders, and shall develop crisis intervention training tools for use by first responders (as such term is defined in section 10705 of this title) that provide—
    (1) information on the conditions and symptoms of a traumatic brain injury, an acquired brain injury, and post-traumatic stress disorder;
    (2) techniques to interact with persons who have a traumatic brain injury, an acquired brain injury, or post-traumatic stress disorder; and
    (3) information on how to recognize persons who have a traumatic brain injury, an acquired brain injury, or post-traumatic stress disorder.

Citations to §10705(1)

Citations to §10705(2)

Citations to §10705(3)

  • 34 U.S.C. § 10701(a)
    Go to provision →
    (a) From amounts made available to carry out this subchapter, the Attorney General may make grants to States, units of local government, and Indian tribes, for use by the State, unit of local government, or Indian tribe to provide services primarily relating to opioid abuse, including for any one or more of the following:
    (1) Developing, implementing, or expanding a treatment alternative to incarceration program, which may include—
    (A) prebooking or postbooking components, which may include the activities described in subchapter XXIX or XXXIII of this chapter;
    (B) training for criminal justice agency personnel on substance use disorders and co-occurring mental illness and substance use disorders;
    (C) a mental health court, including the activities described in subchapter XXI of this chapter;
    (D) a drug court, including the activities described in subchapter XXX of this chapter;
    (E) a veterans treatment court program, including the activities described in subsection (i) of section 10651 of this title;
    (F) a focus on parents whose incarceration could result in their children entering the child welfare system;
    (G) a community-based substance use diversion program sponsored by a law enforcement agency; and
    (H) a pilot program for rural areas to implement community response programs that focus on reducing opioid overdose deaths, which may include presenting alternatives to incarceration, as described in subsection (f).
    (2) In the case of a State, facilitating or enhancing planning and collaboration between State criminal justice agencies and State substance abuse agencies in order to more efficiently and effectively carry out activities or services described in any paragraph of this subsection that address problems related to opioid abuse.
    (3) Providing training and resources for first responders on carrying and administering an opioid overdose reversal drug or device approved or cleared by the Food and Drug Administration, and purchasing such a drug or device for first responders who have received such training to so carry and administer.
    (4) Locating or investigating illicit activities related to the unlawful distribution of opioids.
    (5) Developing, implementing, or expanding a medication-assisted treatment program used or operated by a criminal justice agency, which may include training criminal justice agency personnel on medication-assisted treatment, and carrying out the activities described in subchapter XVIII of this chapter.
    (6) In the case of a State, developing, implementing, or expanding a prescription drug monitoring program to collect and analyze data related to the prescribing of schedules II, III, and IV controlled substances through a centralized database administered by an authorized State agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program in each other State, and with any interstate entity that shares information between such programs.
    (7) Developing, implementing, or expanding a program to prevent and address opioid abuse by juveniles.
    (8) Developing, implementing, or expanding a program (which may include demonstration projects) to utilize technology that provides a secure container for prescription drugs that would prevent or deter individuals, particularly adolescents, from gaining access to opioid medications that are lawfully prescribed for other individuals.
    (9) Developing, implementing, or expanding a prescription drug take-back program.
    (10) Developing, implementing, or expanding an integrated and comprehensive opioid abuse response program.
  • 34 U.S.C. § 10701(a)(1)(H)
    Go to provision →
    (H) a pilot program for rural areas to implement community response programs that focus on reducing opioid overdose deaths, which may include presenting alternatives to incarceration, as described in subsection (f).
  • 34 U.S.C. § 10701(a)(2)
    Go to provision →
    (2) In the case of a State, facilitating or enhancing planning and collaboration between State criminal justice agencies and State substance abuse agencies in order to more efficiently and effectively carry out activities or services described in any paragraph of this subsection that address problems related to opioid abuse.
  • 34 U.S.C. § 10701(a)(3)
    Go to provision →
    (3) Providing training and resources for first responders on carrying and administering an opioid overdose reversal drug or device approved or cleared by the Food and Drug Administration, and purchasing such a drug or device for first responders who have received such training to so carry and administer.
  • 34 U.S.C. § 10701(a)(4)
    Go to provision →
    (4) Locating or investigating illicit activities related to the unlawful distribution of opioids.
  • 34 U.S.C. § 10701(a)(7)
    Go to provision →
    (7) Developing, implementing, or expanding a program to prevent and address opioid abuse by juveniles.
  • 34 U.S.C. § 10701(a)(8)
    Go to provision →
    (8) Developing, implementing, or expanding a program (which may include demonstration projects) to utilize technology that provides a secure container for prescription drugs that would prevent or deter individuals, particularly adolescents, from gaining access to opioid medications that are lawfully prescribed for other individuals.
  • 34 U.S.C. § 10701(a)(10)
    Go to provision →
    (10) Developing, implementing, or expanding an integrated and comprehensive opioid abuse response program.
  • 34 U.S.C. § 10701(f)(1)
    Go to provision →
    (1) The pilot program described under this subsection shall make grants to rural areas to implement community response programs to reduce opioid overdose deaths. Grants issued under this subsection shall be jointly operated by units of local government, in collaboration with public safety and public health agencies or public safety, public health and behavioral health collaborations. A community response program under this subsection shall identify gaps in community prevention, treatment, and recovery services for individuals who encounter the criminal justice system and shall establish treatment protocols to address identified shortcomings. The Attorney General, through the Office of Justice Programs, shall increase the amount provided as a grant under this section for a pilot program by no more than five percent for each of the two years following certification by the Attorney General of the submission of data by the rural area on the prescribing of schedules II, III, and IV controlled substances to a prescription drug monitoring program, or any other centralized database administered by an authorized State agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program (including an electronic health records system) in each other State, and with any interstate entity that shares information between such programs.
  • 34 U.S.C. § 10702(4)
    Go to provision →
    (4) An assurance that the applicant will work with the Drug Enforcement Administration to develop an integrated and comprehensive strategy to address opioid abuse.
  • 34 U.S.C. § 10704(2)
    Go to provision →
    (2) focuses on communities that have been disproportionately impacted by opioid abuse as evidenced in part by—
    (A) high rates of primary treatment admissions for heroin and other opioids;
    (B) high rates of drug poisoning deaths from heroin and other opioids; and
    (C) a lack of accessibility to treatment providers and facilities and to emergency medical services.
  • 34 U.S.C. § 10704(2)(A)
    Go to provision →
    (A) high rates of primary treatment admissions for heroin and other opioids;
  • 34 U.S.C. § 10704(2)(B)
    Go to provision →
    (B) high rates of drug poisoning deaths from heroin and other opioids; and
  • 34 U.S.C. § 10707(1)
    Go to provision →
    (1) Not later than 5 years after July 22, 2016, the Attorney General shall complete an evaluation of the effectiveness of the Comprehensive Opioid Abuse Grant Program under part LL of title I of the Omnibus Crime Control and Safe Streets Act of 1968 [34 U.S.C. 10701 et seq.] administered by the Department of Justice based upon the information reported under paragraph (4).
  • 34 U.S.C. § 10707(2)
    Go to provision →
    (2) Not later than 3 years after July 22, 2016, the Attorney General shall complete an interim evaluation assessing the nature and extent of the incidence of opioid abuse and illegal opioid distribution in the United States.
  • 34 U.S.C. § 10707(3)
    Go to provision →
    (3) Not later than 180 days after July 22, 2016, the Attorney General shall identify outcomes that are to be achieved by activities funded by the Comprehensive Opioid Abuse Grant Program and the metrics by which the achievement of such outcomes shall be determined.
  • 34 U.S.C. § 10707(4)
    Go to provision →
    (4) The Attorney General shall require grantees under the Comprehensive Opioid Abuse Grant Program (and those receiving subawards under section 3021(b) of part LL of title I of the Omnibus Crime Control and Safe Streets Act of 1968 [34 U.S.C. 10701(b)]) to collect and annually report to the Department of Justice data based upon the metrics identified under paragraph (3).
  • 34 U.S.C. § 10707(6)(B)
    Go to provision →
    (B) enter into a contract or cooperative agreement with an entity that is not an agency of the Federal Government, and is qualified to conduct and evaluate research pertaining to opioid use and abuse, and draw conclusions about overall opioid use and abuse on the basis of that research.

Citations to §10705(5)

  • 34 U.S.C. § 10701(a)(1)(D)
    Go to provision →
    (D) a drug court, including the activities described in subchapter XXX of this chapter;
  • 34 U.S.C. § 10701(a)(3)
    Go to provision →
    (3) Providing training and resources for first responders on carrying and administering an opioid overdose reversal drug or device approved or cleared by the Food and Drug Administration, and purchasing such a drug or device for first responders who have received such training to so carry and administer.
  • 34 U.S.C. § 10701(a)(6)
    Go to provision →
    (6) In the case of a State, developing, implementing, or expanding a prescription drug monitoring program to collect and analyze data related to the prescribing of schedules II, III, and IV controlled substances through a centralized database administered by an authorized State agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program in each other State, and with any interstate entity that shares information between such programs.
  • 34 U.S.C. § 10701(a)(8)
    Go to provision →
    (8) Developing, implementing, or expanding a program (which may include demonstration projects) to utilize technology that provides a secure container for prescription drugs that would prevent or deter individuals, particularly adolescents, from gaining access to opioid medications that are lawfully prescribed for other individuals.
  • 34 U.S.C. § 10701(a)(9)
    Go to provision →
    (9) Developing, implementing, or expanding a prescription drug take-back program.
  • 34 U.S.C. § 10701(f)(1)
    Go to provision →
    (1) The pilot program described under this subsection shall make grants to rural areas to implement community response programs to reduce opioid overdose deaths. Grants issued under this subsection shall be jointly operated by units of local government, in collaboration with public safety and public health agencies or public safety, public health and behavioral health collaborations. A community response program under this subsection shall identify gaps in community prevention, treatment, and recovery services for individuals who encounter the criminal justice system and shall establish treatment protocols to address identified shortcomings. The Attorney General, through the Office of Justice Programs, shall increase the amount provided as a grant under this section for a pilot program by no more than five percent for each of the two years following certification by the Attorney General of the submission of data by the rural area on the prescribing of schedules II, III, and IV controlled substances to a prescription drug monitoring program, or any other centralized database administered by an authorized State agency, which includes tracking the dispensation of such substances, and providing for interoperability and data sharing with each other such program (including an electronic health records system) in each other State, and with any interstate entity that shares information between such programs.
  • 34 U.S.C. § 10701(f)(2)(B)
    Go to provision →
    (B) limit or prohibit the discretion of a prescription drug monitoring program for interoperability connections to other programs (including electronic health records systems, hospital systems, pharmacy dispensing systems, or health information exchanges).
  • 34 U.S.C. § 10702(4)
    Go to provision →
    (4) An assurance that the applicant will work with the Drug Enforcement Administration to develop an integrated and comprehensive strategy to address opioid abuse.
  • 34 U.S.C. § 10704(2)(B)
    Go to provision →
    (B) high rates of drug poisoning deaths from heroin and other opioids; and

Citations to §10705(6)

Citations to §10705(7)

Citations to §10705(8)